secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001493152-26-007574
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics raises ~$61.5k via three convertible notes at 35% discount
-----------------------------------------------------------------------------

- Entered three convertible note purchase agreements with Brio Capital, Osher Capital, and Lambda Venture Partners.
- Total principal amount of $72,222.21 (~$61,500 net proceeds) at 8% interest per annum.
- Notes convertible into common stock at a 35% discount to the lowest traded price over prior 20 trading days.
- No warrants issued; issuance exempt under Section 4(a)(2) as sales to sophisticated investors.
- Notes have a one-year maturity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315226007574/0001493152-26-007574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315226007574/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer